Erlotinib in Patients With Resected, Early Stage NSCLC With Confirmed Mutations in the EGFR

Clinical Trial ID NCT00567359

PubWeight™ 2.96^‹?›

🔗 Visit the ClinicalTrials.gov page for NCT00567359

Top papers